KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 12,740
+10 (0.08%)
At close: Mar 6, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 132.3 billion as of March 9, 2026. Its market cap has decreased by -20.46% in one year.
Market Cap
132.30B
Enterprise Value
137.11B
Revenue
90.11B
Ranking
n/a
PE Ratio
759.66
Stock Price
12,740.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 132.30B, a decrease of -28.01%. That is a compound annual growth rate of -5.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 138.95B | -2.00% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 187.36B |
| OPTUS Pharmaceutical | 186.35B |
| GREEN CROSS WellBeing | 168.05B |
| High Tech Pharm | 166.94B |
| Kyung Dong Pharmaceutical | 148.18B |
| DongKoo Bio & Pharma | 145.49B |
| PHARMARESEARCH BIO | 131.48B |
| HYUNDAI BIOLAND | 124.95B |